Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.

García Rodríguez LA, Lin KJ, Hernández-Díaz S, Johansson S.

Circulation. 2011 Mar 15;123(10):1108-15. doi: 10.1161/CIRCULATIONAHA.110.973008. Epub 2011 Feb 28.

2.

Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.

González-Pérez A, Sáez ME, Johansson S, Himmelmann A, García Rodríguez LA.

BMC Cardiovasc Disord. 2016 Aug 30;16(1):164. doi: 10.1186/s12872-016-0348-6.

3.

Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.

Sáez ME, González-Pérez A, Johansson S, Nagy P, García Rodríguez LA.

Am J Cardiovasc Drugs. 2014 Dec;14(6):443-50. doi: 10.1007/s40256-014-0088-x.

PMID:
25119521
4.

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S, Güell M, de Argila CM, Quintero E, Borda F, Piqué JM; Asociación Española de Gastroenterología.

Gut. 2006 Dec;55(12):1731-8. Epub 2006 May 10.

5.

Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.

Cea Soriano L, Bueno H, Johansson S, García Rodríguez LA.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):463-9. doi: 10.1002/pds.3195. Epub 2012 Feb 1.

PMID:
22298501
6.

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Delaney JA, Opatrny L, Brophy JM, Suissa S.

CMAJ. 2007 Aug 14;177(4):347-51.

7.

Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.

Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, Lee FY.

Aliment Pharmacol Ther. 2013 Nov;38(9):1119-28. doi: 10.1111/apt.12483. Epub 2013 Sep 15.

8.

Risk of upper gastrointestinal bleeding from different drug combinations.

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC.

Gastroenterology. 2014 Oct;147(4):784-792.e9; quiz e13-4. doi: 10.1053/j.gastro.2014.06.007. Epub 2014 Jun 14.

PMID:
24937265
9.

Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

Lanas Á, Carrera-Lasfuentes P, Arguedas Y, García S, Bujanda L, Calvet X, Ponce J, Perez-Aísa Á, Castro M, Muñoz M, Sostres C, García-Rodríguez LA.

Clin Gastroenterol Hepatol. 2015 May;13(5):906-12.e2. doi: 10.1016/j.cgh.2014.11.007. Epub 2014 Nov 14.

PMID:
25460554
10.

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.

Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J; Investigators of the Asociación Española de Gastroenterología (AEG).

Am J Gastroenterol. 2007 Mar;102(3):507-15.

PMID:
17338735
11.

Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.

Nagata N, Niikura R, Aoki T, Shimbo T, Kishida Y, Sekine K, Tanaka S, Watanabe K, Sakurai T, Yokoi C, Akiyama J, Yanase M, Mizokami M, Uemura N.

J Gastroenterol Hepatol. 2014 Oct;29(10):1786-93. doi: 10.1111/jgh.12595.

PMID:
24720424
12.

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E.

CMAJ. 2011 Nov 8;183(16):1835-43. doi: 10.1503/cmaj.100912. Epub 2011 Sep 26.

13.

Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.

Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):489-95.

14.

Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.

Lin KJ, Hernández-Díaz S, García Rodríguez LA.

Gastroenterology. 2011 Jul;141(1):71-9. doi: 10.1053/j.gastro.2011.03.049. Epub 2011 Mar 31.

PMID:
21458456
15.

Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.

Cea Soriano L, Rodríguez LA.

Front Pharmacol. 2010 Oct 14;1:126. doi: 10.3389/fphar.2010.00126. eCollection 2010.

16.

Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.

de Groot NL, Hagenaars MP, Smeets HM, Steyerberg EW, Siersema PD, van Oijen MG.

J Gastroenterol. 2014 Feb;49(2):245-53. doi: 10.1007/s00535-013-0817-y. Epub 2013 Apr 23.

PMID:
23609946
17.

Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding.

Younossi ZM, Strum WB, Schatz RA, Teirstein PS, Cloutier DA, Spinks TJ.

Dig Dis Sci. 1997 Jan;42(1):79-82.

PMID:
9009119
18.

Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.

Huang KW, Luo JC, Leu HB, Huang CC, Hou MC, Chen TS, Lu CL, Lin HC, Lee FY, Chang FY.

J Chin Med Assoc. 2013 Jan;76(1):9-14. doi: 10.1016/j.jcma.2012.09.004. Epub 2012 Dec 20.

19.

Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.

Nagata N, Niikura R, Aoki T, Sakurai T, Moriyasu S, Shimbo T, Sekine K, Okubo H, Watanabe K, Yokoi C, Yanase M, Akiyama J, Uemura N.

J Gastroenterol. 2015 Nov;50(11):1079-86. doi: 10.1007/s00535-015-1055-2. Epub 2015 Feb 21.

PMID:
25700638
20.

Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.

Sawhney MS, McDougall H, Nelson DB, Bond JH.

Dig Dis Sci. 2010 Jun;55(6):1637-42. doi: 10.1007/s10620-010-1150-4. Epub 2010 Mar 3.

PMID:
20195757

Supplemental Content

Support Center